Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Bruno Verza Azevedo
Observed names:
B Azevedo,
Bruno Azevedo
Institutions:
Universidade de São Paulo,
Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
Observed institutions:
Universidade de São Paulo,
Universidade Estadual de Campinas (UNICAMP),
Hospital Felício Rocho,
Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
ORCID:
0009-0003-9848-9093
Observed ORCIDs:
0009-0003-9848-9093,
0000-0001-6308-2806
OpenAlex ID:
A5049783363
AML-840: Dose-Reduced Venetoclax-Azacitidine in Elderly Acute Myeloid Leukemia: A Real-World Experience
2025
·
Viviane Sousa
, E Fagundes
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
·
1
Cost-effectiveness Analysis of Rituximab Associated With Fludarabine and Cyclophosphamide (R-FC) for the First-line Treatment of Chronic Lymphocytic Leukemia Under the Brazilian Public Health System (SUS).
2021
·
Bruno Azevedo
, Adriana Carvalho
, et al.
·
1
PDF
Differences in the clinical profile between isolated lupus anticoagulant and triplepositive antiphospholipid antibody profiles in primary antiphospholipid syndrome
2026
·
Bruno Verza Azevedo
, Flavio Signorelli
, et al.
·
Einstein (São Paulo)
PDF
POSTER: AML-840 Dose-Reduced Venetoclax-Azacitidine in Elderly Acute Myeloid Leukemia: A Real-World Experience
2025
·
Viviane Sousa
, E Fagundes
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
Comparison of Single Lupus Anticoagulant Positivity Versus Triple Positivity in Primary Antiphospholipid Syndrome Patients
2023
·
Bruno Verza Azevedo
, Danieli Castro Oliveira de Andrade
, et al.
·
Congresso Brasileiro de Reumatologia
PDF
Show more works
View as search
Works count:
5
Citation count:
2
H-index:
1
I10-index:
Year
Topic
Type